Ryman Healthcare Limited logo

Ryman announces opening of Retail Offer

Capital Raise20 February 2023RYMHealthcare

NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES

21 February 2023


Ryman announces opening of Retail Entitlement Offer


On 15 February 2023, Ryman announced it was raising $902 million through a 1 for

2.81 accelerated pro rata entitlement offer of new ordinary shares (New Shares),

with trading of retail entitlements on the NZX (the Offer).


The purpose of the Offer is to reset Ryman’s capital structure, provide funds to

strengthen its balance sheet through the repayment of debt and better enable the

company to execute its growth framework.


Having successfully completed the institutional component of the Offer last Friday, 17

February 2023, raising $542 million (subject to final reconciliation of institutional

entitlements), Ryman is now pleased to invite eligible retail shareholders to participate

in the retail component of the Offer (Retail Entitlement Offer) from today until

5:00pm NZDT on Monday, 6 March 2023.


Under the Retail Entitlement Offer, eligible retail shareholders are now being invited

to subscribe for New Shares at an Offer Price of $5.00, which represents a 17.1%

discount to the theoretical ex-rights price.

1



Eligible retail shareholders have a number of options under the Retail Entitlement

Offer, as follows:



Elect to subscribe for all or part of their pro rata entitlements from 9:00am

today until 5:00pm on the Retail Entitlement Offer close date of Monday, 6

March 2023



Those who elect to subscribe for all of their entitlements can also apply to

subscribe for additional New Shares in the retail shortfall bookbuild



Sell or transfer all or some of their retail entitlements – retail entitlements

began trading on the NZX yesterday and will continue to trade until Tuesday,

28 February 2023


1

TERP is a theoretical calculation only and the actual price at which Ryman shares trade on the NZX

immediately after the ex date for the Entitlement Offer will depend on many factors and may not be

equal to TERP.





Do nothing and let new shares attributable to their retail entitlements be

offered for sale through the retail shortfall bookbuild


Further details on the Retail Entitlement Offer and the retail shortfall bookbuild,

including key dates and how to apply, are set out in the Offer Document, which is

available to eligible retail shareholders at https://ryman.capitalraise.co.nz.


The Offer Document should be read in conjunction with the Investor Presentation and

Ryman's other market releases which are available at www.nzx.com under the ticker

code “RYM” and contain important information about Ryman and risks associated with

an investment in Ryman. Eligible retail shareholders and other eligible investors are

encouraged to read that information carefully. If in any doubt about whether or not

to apply for New Shares, you should consult with a financial or other professional

advisor.






About Ryman:

Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 45

retirement villages in New Zealand and Australia. Ryman villages are home to

approximately 13,700 residents, and the company employs approximately 6,800 staff.


Contacts:


Investor queries:


Hayden Strickett, Head of Investor Relations,

+64 27 303 1132 or hayden.strickett@rymanhealthcare.com


Media queries: Marsha Cadman, Chief Sales and Marketing Officer

+61 414 790 480 or marsha.cadman@rymanhealthcare.com





Important Notice

The details in this announcement provide general information only. It is not intended as investment,

legal, tax or financial advice or recommendation to any person and must not be relied on as such. You

should obtain independent professional advice prior to making any decision relating to your investment

or financial needs.

No product disclosure statement or prospectus has been prepared in respect of the Offer. A

presentation titled "Capital structure and Entitlement offer investor presentation" providing further

important information in relation to Ryman and the Offer was published by Ryman on 15 February 2023

(the Investor Presentation). A copy of the Investor Presentation is available at www.nzx.com under the

ticker code "RYM". The Investor Presentation includes details of the rationale for the Offer. It also

provides a trading update and explains in more detail the expected impact of the Offer, including a non-

exhaustive summary of certain key risks associated with Ryman and the Offer. You should read the

Investor Presentation in full, as it contains important information to assist you in making an investment

decision in respect of the Offer. In particular, you should read and consider Appendix 2 of the Investor

Presentation ("Key Risks") before making an investment decision. Ryman is subject to continuous

disclosure obligations under the NZX Listing Rules which require it to notify certain material

information to NZX. Market releases by Ryman are available at www.nzx.com under the ticker code

"RYM". Ryman recommends that you read its market releases lodged with NZX.

All references to $ are to New Zealand dollars unless otherwise indicated.

This announcement contains certain forward-looking statements such as indications of, and guidance on,

future earnings and financial position and performance. Forward-looking statements can generally be

identified by use of words such as 'approximate', 'project', 'foresee', 'plan', 'target', 'seek', 'expect', 'aim',

'intend', 'anticipate', 'believe', 'estimate', 'may', 'should', 'will', 'objective', 'assume', 'guidance', 'outlook' or

similar expressions. This also includes statements regarding the timetable, conduct and outcome of the

Offer and the use of proceeds thereof, statements about the plans, targets, objectives and strategies of

Ryman and statements about the future performance of and outlook for, Ryman's business, including the

Company's development pipeline, the Company's guidance and outlook for FY24 and statements in

respect of the Company's outstanding debt. Any indications of, or guidance or outlook on, future

earnings or financial position or performance and future distributions are also forward-looking

statements. All such forward-looking statements involve known and unknown risks, significant

uncertainties, judgements, assumptions, contingencies, and other factors, many of which are outside the

control of Ryman, are difficult to predict, and which may cause the actual results or performance of

Ryman to be materially different from any future results or performance expressed or implied by such

forward-looking statements

This communication is not for distribution or release in the United States. This communication does

not constitute an offer to sell, or the solicitation of an offer to buy, any securities in the United States.

The entitlements and the New Shares have not been, and will not be, registered under the U.S.

Securities Act of 1933, as amended (U.S. Securities Act), or the securities laws of any state or other

jurisdiction of the United States, and may not be offered or sold, directly or indirectly, in the United

States or to any person acting for the account or benefit of any person in the United States (to the

extent such person is acting for the account or benefit of a person in the United States). Under the

Retail Entitlement Offer, the Entitlements may only be exercised, and the New Shares may only be

offered and sold outside the United States, in “offshore transactions” (as defined in Rule 902(h) under

the U.S. Securities Act) in reliance on Regulation S under the U.S. Securities Act.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.